Your browser doesn't support javascript.
loading
The effects of acute alcohol administration on circulating endocannabinoid levels in humans.
Sloan, Matthew E; Grant, Caroline W; Stangl, Bethany L; Klepp, Timothy D; Brewton, Honoree W; Cinar, Resat; Kunos, George; Ramchandani, Vijay A.
Afiliação
  • Sloan ME; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Grant CW; Division of Neurosciences and Clinical Translation, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Stangl BL; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Klepp TD; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Brewton HW; Department of Psychological Clinical Science, University of Toronto Scarborough, Toronto, Ontario, Canada.
  • Cinar R; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.
  • Kunos G; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.
  • Ramchandani VA; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.
Addict Biol ; 27(5): e13197, 2022 09.
Article em En | MEDLINE | ID: mdl-36001429
ABSTRACT
Several lines of evidence suggest that endocannabinoid signalling may influence alcohol consumption. Preclinical studies have found that pharmacological blockade of cannabinoid receptor 1 leads to reductions in alcohol intake. Furthermore, variations in endocannabinoid metabolism between individuals may be associated with the presence and severity of alcohol use disorder. However, little is known about the acute effects of alcohol on the endocannabinoid system in humans. In this study, we evaluated the effect of acute alcohol administration on circulating endocannabinoid levels by analysing data from two highly-controlled alcohol administration experiments. In the first within-subjects experiment, 47 healthy participants were randomized to receive alcohol and placebo in a counterbalanced order. Alcohol was administered using an intravenous clamping procedure such that each participant attained a nearly identical breath alcohol concentration of 0.05%, maintained over 3 h. In the second experiment, 23 healthy participants self-administered alcohol intravenously; participants had control over their exposure throughout the paradigm. In both experiments, circulating concentrations of two endocannabinoids, N-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG), were measured at baseline and following alcohol exposure. During the intravenous clamping procedure, acute alcohol administration reduced circulating AEA but not 2-AG levels when compared to placebo. This finding was confirmed in the self-administration paradigm, where alcohol reduced AEA levels in an exposure-dependent manner. Future studies should seek to determine whether alcohol administration has similar effects on brain endocannabinoid signalling. An improved understanding of the bidirectional relationship between endocannabinoid signalling and alcohol intake may deepen our understanding of the aetiology and repercussions of alcohol use disorder.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endocanabinoides / Alcoolismo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Addict Biol Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endocanabinoides / Alcoolismo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Addict Biol Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá